Response to: 'Clinical features of patients with rheumatic diseases and COVID-19 infection in Sarawak, Malaysia' by Wan <i>et al</i>.

Zhong, Jixin; Dong, Lingli

Response to: 'Clinical features of patients with rheumatic diseases and COVID-19 infection in Sarawak, Malaysia' by Wan et al.

Zhong, Jixin; Dong, Lingli.

Zhong J; Department of Rheumatology and Immunlogy, Tongji Hospital of Tongji Medical College of Huazhong University of Science and Technology, Wuhan, China zhongjixin620@163.com tjhdongll@163.com.
Dong L; Department of Rheumatology and Immunlogy, Tongji Hospital of Tongji Medical College of Huazhong University of Science and Technology, Wuhan, China zhongjixin620@163.com tjhdongll@163.com.

Ann Rheum Dis ; 81(8): e149, 2022 08.

Article in English | MEDLINE | ID: covidwho-679538

Subject(s)

COVID-19; Rheumatic Diseases; Humans; Malaysia/epidemiology; Rheumatic Diseases/complications

Keywords

antirheumatic agents; immune system diseases; therapeutics

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Rheumatic Diseases / COVID-19 Type of study: Observational study / Prognostic study Topics: Long Covid Limits: Humans Country/Region as subject: Asia Language: English Journal: Ann Rheum Dis Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google